Health Trials

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

ConditionHepatic Fibrosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-65
SponsorSohag University

About this trial

Metabolic dysfunction asociated steatotic liver disease prevalence is 25%world wide diabetic patients have a risk for MASLD then have hepatic fibrosis so we study correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic fibrosis In Metabolic dysfunction asociated steatotic liver disease in patients with type2 Diabetes Mellitus

Eligibility criteria

Qualifiers

patients of both sex who have type2 Diabetes Mellitus for less than five years

Disqualifiers

None

Trial design

Treatments tested in this trial

  • serum Adiponectine and Resistin
  • fibroscan

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Sohag University

Lead sponsor

Source ClinicalTrials.gov